12:00 AM
 | 
Oct 01, 2012
 |  BC Week In Review  |  Company News  |  Deals

Evotec, Boehringer Ingelheim deal

Evotec received a €2.5 million ($3.2 million) milestone payment from Boehringer under an amended 2004 deal to jointly identify and develop...

Read the full 84 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >